Bio-Works Technologies AB
STO:BIOWKS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Bio-Works Technologies AB
Inventory
Bio-Works Technologies AB
Inventory Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
Bio-Works Technologies AB
STO:BIOWKS
|
Inventory
kr9.1m
|
CAGR 3-Years
12%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
O
|
OssDsign AB
STO:OSSD
|
Inventory
kr22.7m
|
CAGR 3-Years
73%
|
CAGR 5-Years
62%
|
CAGR 10-Years
N/A
|
|
|
Xvivo Perfusion AB
STO:XVIVO
|
Inventory
kr248.5m
|
CAGR 3-Years
33%
|
CAGR 5-Years
33%
|
CAGR 10-Years
24%
|
|
|
D
|
Doxa AB
STO:DOXA
|
Inventory
kr0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bactiguard Holding AB
STO:BACTI B
|
Inventory
kr21.9m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
|
V
|
Vimian Group AB
STO:VIMIAN
|
Inventory
€80.1m
|
CAGR 3-Years
9%
|
CAGR 5-Years
27%
|
CAGR 10-Years
N/A
|
|
Bio-Works Technologies AB
Glance View
Bio-Works Technologies AB engages in the research and development, manufacturing, and supply of agarose-based resins. The company is headquartered in Uppsala, Uppsala. The company went IPO on 2017-12-14. The firm designs, develops, manufactures and supplies products for purification and separation of proteins and other molecules for application in areas such as Research and Laboratory, Life Science and Biopharma, as well as Food and Beverage. The firm uses technology based on uses Agarose beads, which are derived from seaweed in the process of liquid chromatography and serve as adsorbers that bind molecules of interest allowing them to be recovered. Its product offerings, marketed under brand names WorkBeads, BabyBio and OptioBio, include Activated Resin for coupling ligands, BabyBio Columns for rapid protein purification and condition screening, Immobilized Metal-ion Affinity Chromatography (IMAC) Resin, Ion Exchange Chromatography (IEX) Resin and OptioBio Glass Columns for small-scale purification and screening, among others.
See Also
What is Bio-Works Technologies AB's Inventory?
Inventory
9.1m
SEK
Based on the financial report for Dec 31, 2023, Bio-Works Technologies AB's Inventory amounts to 9.1m SEK.
What is Bio-Works Technologies AB's Inventory growth rate?
Inventory CAGR 5Y
9%
Over the last year, the Inventory growth was -6%. The average annual Inventory growth rates for Bio-Works Technologies AB have been 12% over the past three years , 9% over the past five years .
